Tau Biomarker Expands Beyond Alzheimer’s

• March 25, 2026

Sex Disparities May Persist in CF Despite Modulators

Review findings suggested female patients with cystic fibrosis may continue to experience worse pulmonary outcomes despite highly effective modulator therapy

• by Andrea Surnit

• May 22, 2026

• 6 min

Armed Conflict and Penetrating Traumatic Brain Injury in Children in the Gaza Strip

• by Mohammed Asfa, Joakim Stray Andreassen, Abdul Basit Khan, Geir Stray Andreassen, Mohammed A. K. Matar, Alaa A. A. Alaqad, Ihab Z. D. Nassar, Moath A. J. Albhnasawi, Øyvind Olav Salvesen, Sasha Gulati, Nidal Abuhadrous

• May 15, 2026

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics

• by Rocío Maseda, María Carmen Arriba, Lucía Martínez-Santamaría, Eva Jiménez, Sara Herráiz-Gil, Nuria Illera, Lucía Quintana-Castanedo, Marta García, Susana Suárez-Sancho, Rosa Yáñez, Isabel Pérez-Conde, Marta Carretero, Magdalena Martínez-Queipo, Raquel de Paz, Carlos León, Víctor Jiménez-Yuste, Alberto M. Borobia, Ángeles Vicente, Su M. Lwin, John A. McGrath, María Eugenia Fernández-Santos, Nora Butta, Rosa Sacedón, Marcela del Río, Raúl de Lucas, María José Escámez

• May 5, 2026